Concepedia

Kou Kou

KK

Statistics

Publications

21

Citations

963

H-Index

15

Active since

2003

Affiliations

Queensland University of Technology(Current)

Pfizer (United States)

Cancer Council Queensland

Griffith University

Shandong Center for Disease Control and Prevention

Kou Kou is an author at Queensland University of Technology specializing in oncology, epidemiology, and medicine.

Publications per year

2003–2023

21

Publications

21

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Roberto A. Calle, Neeta B. Amin, Santos Carvajal‐Gonzalez et al. · Nature Medicine · 2021 · 219 citations

Medicine, Pharmacology, Pharmacotherapy +9

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations

Medicine, Oncology, Pharmacology +16

Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver

Angela Hall, Kou Kou, Zhouji Chen et al. · Journal of Lipid Research · 2012 · 92 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction

Jemy A. Gutierrez, Wei Liu, Sylvie Perez et al. · Molecular Metabolism · 2021 · 84 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)

Kentaro Futatsugi, Daniel W. Kung, Suvi T. M. Orr et al. · Journal of Medicinal Chemistry · 2015 · 83 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 21